Eurofins Amatsigroup ǀ Your cDmo partner
Eurofins Amatsigroup is a leading international CDMO focusing on drug product development for chemical/biological entities and drug substance development for biologics. See Frédéric Gaussens, VP BD & Strategy, ITW at 2018 CPhI and learn more about our key expertises (highly potent compounds, poorly soluble drugs, lyophilisation processes, immunotherapies, orphan drugs, pediatric dosage forms…). https://www.eurofins.com/cdmo
Video taken at CPhI worldwide, October 2018.